NIH Weekly Funding Opportunities and Policy Notices
Funding Opportunity PA-17-296 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Exploratory/Developmental Research Grant Award (R21) applications to study molecular and cellular mechanisms of tissue injury and repair associated with alcohol use in humans. Excessive alcohol consumption has the potential to adversely affect multiple organ systems including the liver, brain, heart, pancreas, lung, kidney, endocrine and immune systems, as well as bone and skeletal muscle. In addition, there is accumulating evidence that long term alcohol consumption is associated with reduced host capacity for recovery and repair following trauma. The mechanisms for these alcohol-induced effects on tissue injury and repair are currently not fully understood. NIAAA is especially interested in integrative research that elucidates alcohols effects on complex mechanisms of injury and repair that are either common or specific to each organ system. This FOA also encourages the study of alcohols effect on stem cells, embryonic development, and regeneration. Also encourages are studies on molecular and cellular actions of moderate alcohol consumption. A better understanding of these underlying mechanisms may provide new avenues for developing more effective and novel approaches for prognosis, diagnosis, intervention, and treatment of alcohol-induced organ damage.
Funding Opportunity RFA-HS-17-011 from the NIH Guide for Grants and Contracts. The Agency for Healthcare Research and Quality (AHRQ) will award National Research Service Award (NRSA) Institutional Research Training Grants (T32) to eligible domestic institutions to enhance predoctoral and postdoctoral research training and ensure that a diverse and highly trained workforce is available and committed to the generation, translation and dissemination of new scientific evidence and analytical tools that will be used to improve health care delivery in the United States. Research training programs will incorporate didactic, research and career development elements to prepare individuals for careers that will have a significant impact on the health care needs of the Nation.
Funding Opportunity RFA-FD-17-011 from the NIH Guide for Grants and Contracts. Given the importance of the region in exporting human food to the United States, FDA proposes working with a multilateral institution in the region, specifically the Inter-American Institute for Cooperation on Agriculture (IICA), to develop an expert cadre to foster FSMA standards implementation. IICA has been a strong U.S. government partner in Latin America and the Caribbean and can effectively play a pivotal role in FSMA training in the region.
Notice NOT-NR-17-019 from the NIH Guide for Grants and Contracts
Notice NOT-NS-17-028 from the NIH Guide for Grants and Contracts
Notice NOT-HL-17-517 from the NIH Guide for Grants and Contracts
Notice NOT-EB-17-002 from the NIH Guide for Grants and Contracts
Notice NOT-CA-17-066 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AG-18-007 from the NIH Guide for Grants and Contracts. This FOA supports applications for Claude D. Pepper Older Americans Independence Centers (OAICs), centers of excellence in geriatrics research and research education to increase scientific knowledge leading to better ways to maintain or restore independence in older persons. The OAIC awards are designed to develop or strengthen awardee institutions programs that focus and sustain progress on a key area in aging research related to the mission of the OAIC program.
Funding Opportunity RFA-FD-17-006 from the NIH Guide for Grants and Contracts. This award is intended to provide support to conduct clinical studies at a clinical site with capability and patients samples to investigate potential biomarker (cMLC1) for trastuzumab-induced cardiotoxicity.
Notice NOT-NR-17-018 from the NIH Guide for Grants and Contracts
Notice NOT-HL-17-515 from the NIH Guide for Grants and Contracts
Notice NOT-HL-17-514 from the NIH Guide for Grants and Contracts
Notice NOT-CA-17-064 from the NIH Guide for Grants and Contracts
Notice NOT-CA-17-065 from the NIH Guide for Grants and Contracts
Notice NOT-AG-17-009 from the NIH Guide for Grants and Contracts
Notice NOT-RM-17-025 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-17-294 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to provide access to a consultative resource for planning activities for late phase (phase II and beyond) single-site or multi-site investigator-initiated clinical trials that address critical clinical questions within the mission of the National Heart, Lung, and Blood Institute (NHLBI) and that require non-traditional clinical trial designs with the opportunity for statistical novelty and/or innovation. The FOA will support the development of feasible and well-designed clinical trials utilizing consultative services provided by the Innovative Clinical Trials Resource (ICTR) (N01).
Notice NOT-HL-17-516 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-17-293 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is designed to facilitate clinical trials that can be completed within a limited timeframe and budget. A broad range of types of exploratory studies may be submitted to this FOA. The trials must address research questions related to the mission and goals of the NIAMS and may evaluate interventions with drugs, biologics, devices, or surgical, dietary, behavioral or rehabilitation therapies.